The American College of Cardiology’s 74th Annual Scientific Session and Expo (ACC.25) convened from March 29 to March 31, 2025, in Chicago, Illinois, serving as a pivotal platform for the latest advancements in cardiovascular medicine. The conference attracted over 280 companies and organizations, showcasing innovations across pharmaceuticals, imaging, devices, health information technology, and services essential for high-quality patient care.
Key Highlights from ACC.25
Major pharmaceutical companies such as Mineralys Therapeutics, AstraZeneca, Novo Nordisk, Eli Lilly, Alnylam Pharmaceuticals, SFJ Pharmaceuticals, SERB Pharmaceuticals, and others were amo...